nusinersen

FDA Drug Profile

nusinersen is listed in the FDA National Drug Code directory with 1 NDC code. Available dosage form: powder.

Drug details

Generic Name
nusinersen
Sponsor
Ionis Pharmaceuticals Inc.
NDC Codes
1
Dosage Forms
POWDER
Active Ingredients
NUSINERSEN

Indications and Usage

1 INDICATIONS AND USAGE SPINRAZA is indicated for the treatment of spinal muscular atrophy (SMA) in pediatric and adult patients. SPINRAZA is a survival motor neuron-2 (SMN2)-directed antisense oligonucleotide indicated for the treatment of spinal muscular atrophy (SMA) in pediatric and adult patients ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.